March Therapeutics, Inc. — Form D
March Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-16. The offering totals $3.0M, of which $2.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-04-16
- Form: D
- Accession: 0001809817-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.7M
- Remaining: $280K
- Investors: 10
- Date of first sale: 2020-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-365174
Issuer
- Name: March Therapeutics, Inc.
- CIK: 0001809817
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 617-294-9558
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Daniel I DeWolf | Director | New York, NY |
| Habib I Haddad | Director | Allston, MA |
| Adam I Mullinax | Director | Allston, MA |
| Clare Ozawa | Director | South San Francisco, CA |
| JEONG SEUK KANG | Director | REDWOOD CITY, CA |
| JEONG SEUK KANG | Executive Officer | REDWOOD CITY, CA |
| Fahim Farzadfard | Director | Cambridge, MA |
| Fahim Farzadfard | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More